Lipoprotein Lipase (LPL) (C-Term) Peptid
Kurzübersicht für Lipoprotein Lipase (LPL) (C-Term) Peptid (ABIN8104526)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- LPL Peptide - C-terminal region
-
Sequenz
- LGYEINKVRA KRSSKMYLKT RSQMPYKVFH YQVKIHFSGT ESETHTNQAF
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-LPL Antibody (ARP60284_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Lipoprotein Lipase (LPL)
-
Hintergrund
-
Background Information: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
Alternative Symbols: HDLCQ11, LIPD
-
Molekulargewicht
- 50kDa
-
Gen-ID
- 4023
-
NCBI Accession
- NP_000228
-
UniProt
- P06858
Target
-